Cargando…
Prognostic role of clinical, pathological and biological characteristics in patients with locally advanced breast cancer.
Forty-two patients with clinical stage IIIA or IIIB breast cancer were treated with neoadjuvant chemotherapy followed by mastectomy and radiotherapy. The median follow-up was 32 months (range 10-72 months) and the median time to progression was 17 months (range 10-30 months). A multivariate analysis...
Autores principales: | Honkoop, A. H., van Diest, P. J., de Jong, J. S., Linn, S. C., Giaccone, G., Hoekman, K., Wagstaff, J., Pinedo, H. M. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1998
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2149927/ https://www.ncbi.nlm.nih.gov/pubmed/9484820 |
Ejemplares similares
-
p53 and P-glycoprotein are often co-expressed and are associated with poor prognosis in breast cancer.
por: Linn, S. C., et al.
Publicado: (1996) -
Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.
por: Honkoop, A. H., et al.
Publicado: (1996) -
Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.
por: Dercksen, M. W., et al.
Publicado: (1993) -
Number of apoptotic cells as a prognostic marker in invasive breast cancer
por: Jong, J S de, et al.
Publicado: (2000) -
Pathology of hereditary breast cancer
por: van der Groep, Petra, et al.
Publicado: (2011)